(CIDRAP News) VaxGen Inc., which lost an $877.5 million contract with the US government for a new anthrax vaccine in December, announced May 24 it was stopping development of the vaccine and said it hopes to license the product to another company.
(CIDRAP News) A new report from Congress' Government Accountability Office (GAO) says key organizations that are the backbone of the US financial industry need to do more to prepare for an influenza pandemic and urges federal regulators to set deadlines for them to complete pandemic plans.
